e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway
Corcoran T. E., Thomas K. M., Myerburg M. M., Muthukrishnan A., Weber L., Frizzell R., Pilewski J. M.
Source:
Eur Respir J 2010; 35: 781-786
Journal Issue:
April
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Corcoran T. E., Thomas K. M., Myerburg M. M., Muthukrishnan A., Weber L., Frizzell R., Pilewski J. M.. Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway. Eur Respir J 2010; 35: 781-786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung
Source: Eur Respir J 2016; 47:1392-1401
Year: 2016
Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis
Source: Eur Respir J 2001; 18: 316-322
Year: 2001
Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
The assesment of aerosol solution lung deposition in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004
Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance
Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics
Year: 2007
Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Application of 99mTc-DTPA aerosol in evaluation of pulmonary epithelial permeability
Source: Eur Respir J 2003; 22: Suppl. 45, 593s
Year: 2003
Pharmacological airway clearance strategies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 239-247
Year: 2011
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Source: Eur Respir J 2004; 24: 95-100
Year: 2004
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Lung clearance index and lung ultrasound in cystic fibrosis children
Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring
Year: 2018
New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006
A mathematical model to understand the airway clearance in cystic fibrosis
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept